Commercialization: Page 3


  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: CinCor Pharma's Terry Coelho

    From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off. 

    By July 6, 2022
  • Geometric illustration of multi-colored human figures
    Image attribution tooltip
    iStock via Getty Images

    Pharma companies take a fresh approach to inclusion in new DTC ads

    AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.

    By July 5, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Novartis' Marie-France Tschudin

    How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.

    By June 29, 2022
  • Oral contraceptive pill on pharmacy counter with colorful pills strips background.
    Image attribution tooltip
    iStock via Getty Images

    With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control's pain points

    The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.

    By June 28, 2022
  • Stock Market trading charts on display.
    Image attribution tooltip
    iStock via Getty Images

    A myriad of blows: Who's getting hit the hardest by the economy's troubles

    The downturn shows few signs of hurting large pharma, but small biotechs and generics makers could face a credit crunch.

    By Kim Ribbink • June 27, 2022
  • Image attribution tooltip
    Drew Angerer / Staff via Getty Images

    TikTok tutorial: How pharma can embrace the video platform's educational potential

    Ogilvy Health’s director of social strategy, Katie Ferrigno, busts myths and provides tips on how biopharmas can take advantage of TikTok’s unique features to connect with patients.

    By June 15, 2022
  • Medicare enrollment form and money.
    Image attribution tooltip
    iStock via Getty Images

    Aduhelm's Medicare woes leave questions about lofty premiums

    A single drug’s effect on the premiums that Medicare beneficiaries pay is raising questions about how these levels are set and what factors play a part.

    By Kelly Bilodeau • June 2, 2022
  • Avak Kahvejian
    Image attribution tooltip

    Permission granted by Flagship Pioneering/Avak Kahvejian.

    Profile

    Flagship's creative approach to finding the next big idea in biopharma

    Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

    By Alexandra Pecci • June 1, 2022
  • UNITED STATES - CIRCA 1950s: Interior of Drug Store.
    Image attribution tooltip
    George Marks via Getty Images

    PBMs under fire for drug prices defend their worth

    A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they're more than just middlemen.

    By May 26, 2022
  • Dozens of orange prescription bottles with white caps and labels layered in a jumple.
    Image attribution tooltip
    iStock via Getty Images
    Q&A

    Ironwood Pharmaceuticals is charting a course to become a giant in GI

    Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market. 

    By May 19, 2022
  • Image attribution tooltip
    John Moore via Getty Images

    A potential COVID-19 EUA could turn this small biotech into a household name

    Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.

    By May 19, 2022
  • A doctor holding tablets of medicine explains options to a patient in a hospital room.
    Image attribution tooltip
    iStock via Getty Images

    It's time to acknowledge access as a prescribing barrier

    A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

    By May 11, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A // Biotech Spotlight

    Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

    With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.

    By May 9, 2022
  • Image attribution tooltip

    Adobe Stock / Song about summer

    Sponsored by EVERSANA

    Right-sizing the channel strategy for maximum impact

    Failure to right-size your distribution model imposes financial penalties and wasted expenditures.

    May 9, 2022
  • Close up storyboard content planning of production media of the Blogger or Vlog and the laptop and camera on the desk work.
    Image attribution tooltip
    iStock via Getty Images

    Pharma's solution to the digital advertising dilemma? Storytelling

    Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

    By May 5, 2022
  • Image attribution tooltip
    Stock via Getty Images

    From the fringes to the forefront — the mRNA era has taken hold of pharma

    A look at what’s next for the industry’s buzziest technology.

    By Kim Ribbink • April 22, 2022
  • Image attribution tooltip

    Permission granted by Ted Love. 

    Profile

    For Global Blood Therapeutics, the connection to sickle cell disease runs deep

    An underserved patient population is a guiding light for the company, which recently scored a new approval.

    By Robin Robinson • April 19, 2022
  • In this photo illustration, the Facebook and Instagram apps are seen on the screen of an iPhone on October 04, 2021 in San Anselmo, California.
    Image attribution tooltip
    Justin Sullivan / Staff via Getty Images
    Q&A

    How pharma can up its social media game

    Health Union’s VP of community development, Sara Hayes, discusses how pharma marketers can better reach online patient communities. 

    By April 18, 2022
  • The early morning sun strikes the U.S. Capitol November 6, 2006 in Washington, DC.
    Image attribution tooltip
    Win McNamee/Staff via Getty Images

    How Congress could play a role in personalized medicine

    PGx — a tool to help determine proper dosing — may be poised to achieve broader use in healthcare and pharma.

    By Kelly Bilodeau • April 11, 2022
  • Purulent inflammation of the para nasal sinuses.
    Image attribution tooltip
    Ilya Lukichev via Getty Images

    Optinose CEO senses big opportunities for the company's nasal delivery device

    Peter Miller explains how a repackaged sinus drug has won late-stage clinical success.

    By Jared Whitlock • April 11, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Time-saving tech lights Alcon's path into digital innovation

    Kevin Yapp, global head or omni-channel transformation at the Swiss eye health company shares why the customer should be a  North Star when developing digital tools.

    By Kim Ribbink • April 4, 2022
  • This week's Woman of the Week Sabrina Martucci Johnson shares how she is looking to transform women's health
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Daré Bioscience's Sabrina Martucci Johnson

    The CEO is setting a path to transform women’s health at an opportune time.

    By March 30, 2022
  • Image attribution tooltip

    Permission granted by Alloy.

    Profile

    From media to menopause: Creating new spaces in women's telehealth

    Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women's health startup.

    By Alexandra Pecci • March 29, 2022
  • Image attribution tooltip

    Permission granted by Steve Leber.

    How a rock 'n' roll guru is putting a new spin on health education for patients

    A former agent for The Rolling Stones has launched a healthcare streaming platform with a cast of entertainment heavyweights — and he wants pharma to be a headline act.

    By March 28, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Why Astellas is adopting a 'focus area approach' to partnerships

    Chief Strategy Officer, Naoki Okamura, explains why new trends and innovations require a different approach to alliances.

    By Kim Ribbink • March 22, 2022